← All Sponsors
SPONSOR

Etnova Therapeutics Corp.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaLiver Cancer
NCT06326502 Phase 1
Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
South Korea View Trial →